U.S., March 25 -- ClinicalTrials.gov registry received information related to the study (NCT06891586) titled 'Blood Phoenixin-14 Levels and Echocardiographic Findings in Infants of Diabetic Mothers' on March 11.
Brief Summary: In this study, the investigators hypothesize that echocardiographic pathologies observed in infants of diabetic mothers are associated with elevated serum phoenixin-14 levels.
Study Start Date: Sept. 01, 2023
Study Type: INTERVENTIONAL
Condition:
Newborn Morbidity
Newborn Complication
Intervention:
DIAGNOSTIC_TEST: echocardiographic evaluation and blood phoenixin-14 level
For participants who provide consent, blood samples will be collected at 6 hours postpartum. Additionally, infants included in the study wil...